Digital PCR (dPCR) and Real-time PCR (qPCR) Market Analysis Based on Technology (Droplet digital PCR (ddPCR), Bead-based digital PCR (bdPCR)), Based on Application (Cancer Diagnosis, Infectious Disease Diagnosis, Genetic Disease Diagnosis, Research), Based on End-user (Academic and research institutes, pharmaceutical and biotechnology companies, clinical diagnostic laboratories) & Forecast By 2033
- PUBLISHED ON
- 2023-05-04
- NO OF PAGES
- 274
- CATEGORY
- Healthcare & Life Sciences
Digital PCR (dPCR) and Real-time PCR (qPCR) Market was valued at USD 4,390 million in 2022 and is estimated to display a massive change of USD 6,070 million by 2033. The Digital PCR (dPCR) and Real-time PCR (qPCR) market is estimated to reveal a substantial growth of a CAGR of 7.10% during the forecasted period of 2023 to 2033.
Report Scope
Report Attributes | Description |
Market Forecast in 2022 | USD 4,390 Million |
Market Forecast in 2033 | USD 6,070 Million |
CAGR % 2023-2033 | 7.10% |
Base Year | 2022 |
Historic Data | 2020-2021 |
Forecast Period | 2023-2033 |
Report USP | Product Product, end-user industry, company share, company heatmap, company Capacity Technology Product capacity, growth factors and more |
Segments Covered | Technology, Application, End User |
Regional Scope | North America, Europe, APAC, South America and Middle East and Africa |
Country Scope | U.S.; Canada; U.K.; Germany; France; Italy; Spain; Benelux; Nordic Countries; Russia; China; India; Japan; South Korea; Australia; Indonesia; Thailand; Mexico; Brazil; Argentina; Saudi Arabia; UAE; Egypt; South Africa; Nigeria |
Key Companies | Bio-Rad Laboratories; Thermo Fisher Scientific; RainDance Technologies; Stilla Technologies; JN Medsys; Fluidigm Corporation; Sysmex Corporation; Merck KGaA; Qiagen N.V.; Promega Corporation |
Digital PCR (dPCR) and Real-time PCR (qPCR) Market: Description
Digital PCR (dPCR) and Real-time PCR (qPCR) are two widely used methods in molecular biology that have revolutionized the field of genomics and diagnostics. Both techniques have their unique advantages and disadvantages, and they are used for various applications such as gene expression analysis, genetic disease diagnosis, and cancer diagnosis.
Real-time PCR (qPCR) is a widely used method that has been in use for more than two decades. It is a quantitative method that enables the detection and quantification of specific nucleic acid sequences in a sample. The technique uses fluorescent probes that emit fluorescence when bound to a specific target sequence, which allows the real-time monitoring of the amplification process.
Digital PCR (dPCR) is a newer technique that has gained popularity in recent years. It is a highly precise method that partitions a sample into thousands of tiny droplets, each containing a few DNA molecules. The amplification of the DNA occurs independently in each droplet, and the resulting fluorescence is detected in each droplet. The technique enables the absolute quantification of DNA molecules and is highly sensitive and accurate.
One of the major drivers of the growth in the dPCR market is the increasing demand for liquid biopsy tests for cancer diagnosis. Liquid biopsy tests detect cancer-related biomarkers in bodily fluids such as blood, urine, and cerebrospinal fluid. These tests are non-invasive and provide a less painful alternative to traditional biopsy methods. dPCR is highly sensitive and can detect very low levels of cancer biomarkers in liquid biopsy samples, making it an ideal method for cancer diagnosis.
Another trend in the PCR market is the shift towards automation and high-throughput screening. Automated PCR systems are becoming increasingly popular, as they enable the rapid analysis of large numbers of samples. This is particularly important in the field of diagnostics, where the rapid diagnosis of infectious diseases is critical. Automated PCR systems enable the rapid detection of pathogens and can help to prevent the spread of infectious diseases.
In conclusion, both qPCR and dPCR are widely used methods in molecular biology, and they are expected to continue to grow in popularity in the coming years. The qPCR market is well-established, and the dPCR market is growing rapidly, driven by the increasing demand for liquid biopsy tests and the shift towards automation and high-throughput screening. t.
Digital PCR (dPCR) and Real-time PCR (qPCR) Market- Segmental Analysis:
Technology Insights
Application Insights
Digital PCR has several applications, including liquid biopsy for cancer diagnosis, infectious disease diagnosis, and genetic disease diagnosis. It is also used in research for gene expression analysis, rare mutation detection, and copy number variation analysis.
End User Insights
The Academic and research institutes use digital PCR for basic research, while pharmaceutical and biotechnology companies use it for drug development and clinical trials. Clinical diagnostic laboratories use it for disease diagnosis and monitoring.
Regional Insights
The Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market is further segmented into five major countries- North America, Europe, Asia-pacific, Latin America, Middle East and Africa. North America is the largest market for digital PCR, with the US being the major contributor. The high adoption of advanced technologies in research and diagnostics, coupled with the presence of key players in the region, is driving market growth.
Europe is the second-largest market for digital PCR, with Germany, the UK, and France being the major contributors. The increasing prevalence of chronic diseases and the focus on precision medicine are driving market growth in the region.
Competitive Analysis
Bio-Rad Laboratories; Thermo Fisher Scientific; RainDance Technologies; Stilla Technologies; JN Medsys; Fluidigm Corporation; Sysmex Corporation; Merck KGaA; Qiagen N.V.; Promega Corporation
• In March 2023, Thermo Fisher Scientific announced the launch of a new digital PCR system, the QuantStudio™ 3D Digital PCR System, which is designed to enable researchers to detect and quantify rare mutations and copy number variations with greater sensitivity and precision.
• In January 2023, Bio-Rad Laboratories announced the acquisition of Stilla Technologies, a leading provider of digital PCR technology, for $430 million. The acquisition is expected to expand Bio-Rad's digital PCR portfolio and accelerate its growth in the genomic analysis market.
Digital PCR (dPCR) and Real-time PCR (qPCR) Market - Segmental Analysis
Based on Technology
• Droplet digital PCR (ddPCR)
• Bead-based digital PCR (bdPCR)
Based on Application
• Cancer Diagnosis
• Infectious Disease Diagnosis
• Genetic Disease Diagnosis
• Research
Based on End-User
• Academic and research institutes
• pharmaceutical and biotechnology companies
• clinical diagnostic laboratories
Quality Assurance Process
- We Market Research’s Quality Assurance program strives to deliver superior value to our clients.
We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.
Market Research Process
We Market Research monitors 3 important attributes during the QA process- Cost, Schedule & Quality. We believe them as a critical benchmark in achieving a project’s success.
To mitigate risks that can impact project success, we deploy the follow project delivery best practices:
- Project kickoff meeting with client
- Conduct frequent client communications
- Form project steering committee
- Assign a senior SR executive as QA Executive
- Conduct internal editorial & quality reviews of project deliverables
- Certify project staff in SR methodologies & standards
- Monitor client satisfaction
- Monitor realized value post-project
Case Study- Automotive Sector
One of the key manufacturers of automotive had plans to invest in electric utility vehicles. The electric cars and associated markets being a of evolving nature, the automotive client approached We Market Research for a detailed insight on the market forecasts. The client specifically asked for competitive analysis, regulatory framework, regional prospects studied under the influence of drivers, challenges, opportunities, and pricing in terms of revenue and sales (million units).
Solution
The overall study was executed in three stages, intending to help the client meet its objective of precisely understanding the entire market before deciding on an investment. At first, secondary research was conducted considering political, economic, social, and technological parameters to get a gist of the various aspects of the market. This stage of the study concluded with the derivation of drivers, opportunities, and challenges. It also laid substantial emphasis on understanding and collecting data not only on a global scale but also on the regional and country levels. Data Extraction through Primary Research
The second stage involved primary research in which several market players and automotive parts suppliers were contacted to study their viewpoint concerning the development of their market and production capacity, clientele, and product line. This stage concluded in a brief understanding of the competitive ecosystem and also glanced through the strategies and pricing of the companies profiled.
Market Estimates and Forecast
In the final stage of the study, market forecasts for the electric utility were derived using multiple market engineering approaches. This data helped the client to get an overview of the market and accelerate the process of investment.
Case Study- ICT Sector
Business process outsourcing, being one of the lucrative markets from both supply- and demand- side, has appealed to various companies. One of the prominent corporations based out of Japan approached us with their requirements regarding the scope of the procurement outsourcing market for around 50 countries. Additionally, the client also sought key players operating in the market and their revenue breakdown in terms of region and application.
Business Solution
An exhaustive market study was conducted based on primary and secondary research that involved factors such as labor costs in various countries, skilled and technical labors, manufacturing scenario, and their respective contributions in the global GDP. A comparative study of the market was conducted from both supply- and demand side, with the supply-side comprising of notable companies, such as GEP, Accenture, and others, that provide these services. On the other hand, large manufacturing companies from them demand-side were considered that opt for these services.
Conclusion
The report aided the client in understanding the market trends, including country-level business scenarios, consumer behavior, and trends in 50 countries. The report also provided financial insights of crucial players and detailed market estimations and forecasts till 2033.
Frequently Asked Questions
What is the market size and growth projections?
The Digital PCR (dPCR) and Real-time PCR (qPCR) market was valued at USD 4,390 million in 2022 and is estimated to display a massive change of USD 6,070 million by 2033. The Digital PCR (dPCR) and Real-time PCR (qPCR) market is estimated to reveal a substantial growth of a CAGR of 7.10% during the forecasted period of 2023 to 2033.
What are the drivers shaping various markets?
One of the major drivers of the growth in the dPCR market is the increasing demand for liquid biopsy tests for cancer diagnosis. Liquid biopsy tests detect cancer-related biomarkers in bodily fluids such as blood, urine, and cerebrospinal fluid. These tests are non-invasive and provide a less painful alternative to traditional biopsy methods. dPCR is highly sensitive and can detect very low levels of cancer biomarkers in liquid biopsy samples, making it an ideal method for cancer diagnosis.
Who are the key competitors of market Players?
Some of the major players operating within the market are Bio-Rad Laboratories; Thermo Fisher Scientific; RainDance Technologies; Stilla Technologies; JN Medsys; Fluidigm Corporation; Sysmex Corporation; Merck KGaA; Qiagen N.V.; Promega Corporation.
What are the top performing segments, and countries / regions of each of the markets?
The Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market is further segmented into five major countries- North America, Europe, Asia-pacific, Latin America, Middle East and Africa.
}})
Select a license type that suits your business needs
US $4250
Only Four Thousand Two Hundred Fifty US dollar
- 1 User access
- 15% Additional Free Customization
- Free Unlimited post-sale support
- 100% Service Guarantee until achievement of ROI
US $5250
Only Five Thousand Two Hundred Fifty US dollar
- 5 Users access
- 25% Additional Free Customization
- Access Report summaries for Free
- Guaranteed service
- Dedicated Account Manager
- Discount of 20% on next purchase
- Get personalized market brief from Lead Author
- Printing of Report permitted
- Discount of 20% on next purchase
- 100% Service Guarantee until achievement of ROI
US $6250
Only Six Thousand Two Hundred Fifty US dollar
- Unlimited User Access
- 30% Additional Free Customization
- Exclusive Previews to latest or upcoming reports
- Discount of 30% on next purchase
- 100% Service Guarantee until achievement of ROI